Google Übersetzer
Heron Therapeutics, Inc.
About
Heron Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026
Feb 26 2026
Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results
Feb 17 2026
Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026
Jan 9 2026
Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth
Dec 4 2025
Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)